Continuing challenges in influenza
Top Cited Papers
- 30 May 2014
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1323 (1) , 115-139
Abstract
Influenza is an acute respiratory disease in mammals and domestic poultry that emerges from zoonotic reservoirs in aquatic birds and bats. Although influenza viruses are among the most intensively studied pathogens, existing control options require further improvement. Influenza vaccines must be regularly updated because of continuous antigenic drift and sporadic antigenic shifts in the viral surface glycoproteins. Currently, influenza therapeutics are limited to neuraminidase inhibitors; novel drugs and vaccine approaches are therefore urgently needed. Advances in vaccinology and structural analysis have revealed common antigenic epitopes on hemagglutinins across all influenza viruses and suggest that a universal influenza vaccine is possible. In addition, various immunomodulatory agents and signaling pathway inhibitors are undergoing preclinical development. Continuing challenges in influenza include the emergence of pandemic H1N1 influenza in 2009, human infections with avian H7N9 influenza in 2013, and sporadic human cases of highly pathogenic avian H5N1 influenza. Here, we review the challenges facing influenza scientists and veterinary and human public health officials; we also discuss the exciting possibility of achieving the ultimate goal of controlling influenza's ability to change its antigenicity.Keywords
Funding Information
- National Institutes of Health (HHSN272200900007C)
This publication has 131 references indexed in Scilit:
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferretsNature, 2012
- Broadly neutralizing antibodies against influenza virus and prospects for universal therapiesCurrent Opinion in Virology, 2012
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences, 2010
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus InfectionNew England Journal of Medicine, 2010
- Association of RIG-I with innate immunity of ducks to influenzaProceedings of the National Academy of Sciences, 2010
- T-705 (favipiravir) activity against lethal H5N1 influenza A virusesProceedings of the National Academy of Sciences, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusionProceedings of the National Academy of Sciences, 2008
- Identification of H2N3 influenza A viruses from swine in the United StatesProceedings of the National Academy of Sciences, 2007